🗓️ From 28 to 31 October 2024, the World Vaccine Congress Europe, the most consolidated meeting dedicated to #vaccines arrives in #Barcelona 📍. The conference equips professionals with the tools to transform #healthcare. This year, the congress will host 3000+ attendees, 280 speakers, 150+ exhibitors and plenty of start-ups over the course of 4 days. A must-attend event for all those involved in the development of #vaccines and treatments for rare #diseases, providing a comprehensive view of the scientific, regulatory, and commercial advances in these areas. Free tickets for companies and entities in the #BioRegion of #Catalonia here 👇 https://tuit.cat/fTzfh #WVCEU #WorldVaccineCongress #WorldVaccineCongressEurope #WorldVaccineCongressEurope2024
Biocat, BioRegion of Catalonia
Investigación biotecnológica
Barcelona, Catalonia 33.830 seguidores
Doing now what the BioRegion of Catalonia needs next
Sobre nosotros
Biocat is the institution that promotes the life sciences and healthcare ecosystem in Catalonia and works to maximize its economic and social impact. Biocat’s strategy focuses on positioning the BioRegion of Catalonia as one of the leading European hubs, offering researchers and professionals innovative capacity with programs to improve talent and entrepreneurship, accelerating technology transfer and business growth by supporting TTOs and startups, and helping attract investors and investment to the ecosystem. Created in 2006 by the Government of Catalonia and the Barcelona City Council, Biocat also promotes far-reaching political strategies and projects aimed at contributing to Catalonia’s competitiveness.
- Sitio web
-
http://www.biocat.cat/en
Enlace externo para Biocat, BioRegion of Catalonia
- Sector
- Investigación biotecnológica
- Tamaño de la empresa
- De 11 a 50 empleados
- Sede
- Barcelona, Catalonia
- Tipo
- Organización sin ánimo de lucro
- Fundación
- 2006
- Especialidades
- biotechnology, life sciences, pharmaceuticals, biomedicine, internationalisation, business competitiveness, regional development, cluster management, medtech, digital health, healthcare, innovation, entrepreneurship, biotech, techtransfer, market access y startups
Ubicaciones
-
Principal
Baldiri Reixach, 4-8, Torre I (PCB)
Barcelona, Catalonia 08028, ES
Empleados en Biocat, BioRegion of Catalonia
-
Silvia Labé
Marketing | Communications | Branding | Competitive Intelligence | Strategy. Working to position Catalonia's Life Sciences & Healthcare Innovation…
-
Monica Montero
Head of Business Intelligence at Biocat
-
Ingrid Tarragó
DIRECTORA DE MARCA Y PROMOCIÓN. Creando marcas coherentes y duraderas. Estratega y comunicadora. Apasionada y entusiasta.
-
Robert Fabregat Fuentes
CEO of Biocat
Actualizaciones
-
📢 ICEX and the Economic and Commercial Office of Spain in Chicago are launching the first edition of #DesafíaBoston, an immersion program aimed at innovative Spanish #startups and companies in the #biotech sector, to facilitate their entry into the U.S. market with a program developed by Richi Entrepreneurs 👇 Participants will receive: 💡 #Training specialized in the biotech sector and the U.S. #healthcare system, #health industry regulations, the legal framework for establishing a biotech company in the U.S., and #funding strategies. 💹 They will also be introduced to knowledge, #investment, and #innovation ecosystems in U.S. healthcare, especially in #Boston and the state of #Massachusetts. 🤝 #Networking with leading figures in the biotech ecosystem, visits to #incubators, #hospitals, and #innovation centers in Boston, and customized #B2B meetings. Sign up: 🔗 https://lnkd.in/dENbxt5b
-
-
🛫 The next #Biocat mission to Japan will be from October 7th to 11th! Our team will join the Japanese #healthtech and #biotech ecosystems, which are known as pioneers in regenerative medicine, technology applied to #health, and digitalization. 🤝 Biocat will participate in #partnering events accompanied by the EU-Japan Centre for Industrial Cooperation and the Osaka Prefectural Government in the area of #Osaka. 👥 We will also attend the #BioJapan2024 conference held in #Yokohama, one of the most powerful areas in #innovation and hubs in life sciences. It's one of the most significant #bio and regenerative #medicine congresses in #Asia. More details: https://lnkd.in/dNSEdcKp
-
-
📈 Investment in #AI health companies in Catalonia is increasing! 🩺 In 2023, there were 85 startups and scaleups working on artificial intelligence applied to #health in the #BioRegionCatalonia. More than half (56%) are #DigitalHealth companies, 22% are #biotech companies, and 13% are #medtech companies. Moreover, currently, the #BioRegion has at least 152 #AI tools: 🔺38% in advanced stages 🔺35% in intermediate stages 🔺27% in initial stages 73% of the tools are applied in the hospital environment 🏥. 📋 Check out the #BioRegionReport: https://report.biocat.cat Report promoted by: Biocat, BioRegion of Catalonia With the support of: Amgen, Almirall, AstraZeneca, Cuatrecasas, ESTEVE, and Sanofi. In collaboration with: Catalonia.Health (CataloniaBio & HealthTech), ACCIÓ, Farmaindustria and Fenin, Federación Española de Empresas de Tecnología Sanitaria.
-
-
✍ Note in the agenda: On October 22-25, the World Orphan Drug Congress Europe 2024, the largest and most established global event on orphan drugs and rare diseases, will take place in #Barcelona 📍. Meet over 2000 attendees, connect with 130 exhibitors, and hear from 250 leading experts from the start-to-finish of orphan drugs. This congress addresses specific topics from regulation and policy to global pricing and gene therapy. Free tickets for companies and entities in the #BioRegion of #Catalonia here ➡ https://tuit.cat/xX9yD #WODC #WorldOrphanDrugCongress
-
-
🗞️📺📻 L'any 2023 #Biocat va guanyar més presència als mitjans de comunicació: en total va obtenir +450 impactes a mitjans de comunicació, un 48% més d’impactes respecte al 2022. Biocat, com a entitat impulsora del creixement de l'ecosistema de #ciències de la vida i d'#innovació en #salut de #Catalunya, difon tots els avenços de les empreses i grups de recerca de la #BioRegió, no només gràcies als mitjans de comunicació sinó també a través de canals propis (xarxes socials, web i butlletins) i de l'organització d'esdeveniments per donar a conèixer el potencial de l'ecosistema. La nostra comunitat a xarxes socials no ha parat d'augmentar i ja som més de 52.000 seguidors i seguidores als nostres perfils de #Linkedin, #Instagram i #X 🙌 Si encara no ens seguiu a la resta de xarxes socials, ens trobareu a: 🟪 Instagram: https://lnkd.in/dCbFv2y7 ⬛ X cat: https://x.com/biocat_cat ⬛ X es: https://x.com/biocat_es ⬛ X en: https://x.com/biocat_en 👥 Pel que fa als esdeveniments, n'hem organitzat 31 als quals han assistit més de 800 persones. Coneix les iniciatives i projectes als quals Biocat hi ha dedicat més recursos i que han tingut un impacte més destacable a la Memòria d'activitats 2023 👇 https://tuit.cat/Uc6ga
-
-
🟥 #Biocat is participating in the acceleration program #PatientInnovationBootcamp, led by EIT Health, aiming to promote projects or #startups based on #health solutions devised by patients, family members, or caregivers of people with various illnesses. The Patient Innovation Bootcamp is delivered in a hybrid way, with two weeks of face-to-face stays in #Lisbon and #Copenhagen and online sessions delivered by Biocat from #Barcelona. During the program, teams will validate their product, market, and business model and will be supported by e-learning materials designed to help patient and family teams develop and launch their devices, diagnostic tools, or #DigitalHealth innovations. 👨🎓 From September 30 to October 4, Biocat and IESE Business School will offer a #training week to the selected projects in Barcelona. 💹 In these sessions, participants will learn how to create a successful #business model. All sessions will be held virtually. 💻 More information at: 🔗 https://lnkd.in/erBFT9xN Partners: Biocat, Copenhagen Business School, IESE Business School, NOVA Medical School - Faculdade de Ciências Médicas, Nova School of Business and Economics, and Patient Innovation.
-
-
💹 While global #investment in #DigitalHealth experienced a decline in 2023, #Catalonia defied the trend by not only increasing by 61% compared to the previous year but also approaching its historical peak in 2021, reaching €64 M! This notable growth was primarily attributed to three key operations: Qida (home-care) (💰 €18 M), IOMED (💰 €10 M), and Top Doctors (💰 €8 M). 🥇 The #biotech subsector is the one that attracted the most funding in the #BioRegionCatalonia in 2023, surpassing 110M€! Notable operations included those of SOM Biotech (💰 €17 M), Nuage Therapeutics (💰 €12 M), and Oryzon Genomics SA (💰 €8 M). Likewise, the #medtech subsector, although facing a decline, has successfully rebounded to #investment levels seen before 2021. The three most significant operations in this subsector were INBRAIN Neuroelectronics (💰 €20 M), ADmit Therapeutics (💰 €5.4 M), and deepull Diagnostics (💰 €4 M). 📋 More data in the #BioRegionReport: https://report.biocat.cat/ Promoted by: Biocat, BioRegion of Catalonia With the support of: Amgen, Almirall, AstraZeneca, Cuatrecasas, ESTEVE, and Sanofi. In collaboration with: Catalonia.Health (CataloniaBio & HealthTech), ACCIÓ, Farmaindustria and Fenin, Federación Española de Empresas de Tecnología Sanitaria.
-
-
🔍 Ets una #startup, empresa o institució de #recerca amb base a la #BioRegió de #Catalunya i especialitzada en #ciències de la vida o en el camp de la #salut❓ Vols donar-te a conèixer❓ Registra't al directori de #Biocat i presenta el teu projecte a tot l'ecosistema! La Catalonia #Health and #LifeSciences Data Platform compta amb prop de 1.800 empreses i organitzacions, i permet fer cerques per nom de l’entitat, any de fundació, subsectors, àrees terapèutiques, productes segons la seva fase de desenvolupament, #inversió aixecada i #facturació. 🆓 És una eina oberta, en anglès i de consulta gratuïta per a tothom. 🔄 L’aplicació actual, renovada l’any 2022, està elaborada sobre Salesforce i és actualitzada diàriament per #Biocat. Vols formar-ne part? 📲 https://tuit.cat/23s8v
-
-
El Programa d'Accés de la Innovació al Sistema de Salut de Catalunya ha activat 3⃣ instruments per agilitzar l'arribada de les innovacions més valuoses als pacients: 1️⃣ El Navegador d’Instruments i Programes: un catàleg on trobaràs iniciatives, programes d’incubació i acceleració de l’ecosistema català, eines per validar la proposta de valor dels projectes, suport per superar els requisits reguladors, i molt més. 2️⃣ La Plataforma d’Innovació: és un directori que aglutina de manera endreçada la innovació #tecmed, #DigitalHealth, #biotec i #farma candidata a accedir al Sistema. La plataforma facilita el contacte entre els diferents agents del Sistema i els proveïdors, i ofereix a les innovacions un formulari on poder autoavaluar-se. 3️⃣ La Unitat d’Acompanyament: és un servei d’assessorament liderat per un equip de #Biocat, en col·laboració amb AQuAS i CatSalut, que ofereix acompanyament personalitzat a aquelles innovacions de la Plataforma que hagin estat identificades com a prioritàries pel Sistema. 🎤 Robert Fabregat Fuentes, DG de Biocat, us presenta tots els detalls dels tres instruments en aquest vídeo👇 ▶️ https://tuit.cat/3fheq #PASS és un programa impulsat per #Biocat, amb la col·laboració de l'Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) i el Servei Català de la Salut (#CatSalut).
Presentation of the Catalan Health System innovation Access Program (PASS)
https://www.youtube.com/